Clinical updates, including trial initiations, enrollment status and data readouts and publications: 23andme, Adlai, Affimed, Aligos, Anokion, Avalo, Bluerock, BMS, Bolt, Curis, First Wave, In8bio, Intellia, Nanobiotix, Nimbus, Obseva, Puretech, Rafael, Regeneron, Sapience, Scisparc, SK, Sutro.